During the past decade, Casey Eye Institute conducted 59 clinical trials. In the 10-year time frame, 59 clinical trials started and 30 clinical trials were completed, i.e. on average, 50.8% percent of trials that started reached the finish line to date. In the past 5 years, 27 clinical trials started and 23 clinical trials were completed. i.e. 85.2% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Casey Eye Institute" #1 sponsor was "Jaeb Center for Health Research" with 22 trials, followed by "Oregon Health and Science University" with 13 trials sponsored, "Applied Genetic Technologies Corp" with 7 trials sponsored, "Genentech, Inc." with 4 trials sponsored and "National Eye Institute (NEI)" with 4 trials sponsored. Other sponsors include 41 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Casey Eye Institute" #1 collaborator was "National Eye Institute (NEI)" with 34 trials as a collaborator, "Genentech, Inc." with 6 trials as a collaborator, "National Institutes of Health (NIH)" with 6 trials as a collaborator, "Pediatric Eye Disease Investigator Group" with 6 trials as a collaborator and "Allergan" with 4 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Casey Eye Institute" are "Diabetic Macular Edema" (9 trials), "Geographic Atrophy" (7 trials), "Macular Degeneration" (7 trials), "Diabetic Retinopathy" (6 trials) and "Retinitis Pigmentosa" (6 trials). Many other conditions were trialed in "Casey Eye Institute" in a lesser frequency.

Most popular intervention types in "Casey Eye Institute" are "Drug" (60 trials), "Procedure" (15 trials), "Other" (13 trials), "Device" (10 trials) and "Biological" (9 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Ranibizumab" (4 trials), "Bevacizumab" (3 trials), "Prednisone" (3 trials) and "Sham injection" (3 trials). Other intervention names were less common.

The vast majority of trials in "Casey Eye Institute" are 91 trials for "All" genders and 5 trials for "Male" genders.

Currently, there are NaN active trials in "Casey Eye Institute". undefined are not yet recruiting, 16 are recruiting, 15 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 51 completed trials in Casey Eye Institute, undefined suspended trials, and 12 terminated clinical trials to date.

Out of the total trials that were conducted in Casey Eye Institute, 10 "Phase 1" clinical trials were conducted, 32 "Phase 2" clinical trials and 34 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 7 trials that are defined as “Not Applicable".